Pfiser inks tech deal with VN company

15-Jan-2019 Intellasia | VNS | 6:00 AM Print This Post

Pharmaceutical company Pfiser announced on Thursday it has signed a deal with Medochemie to transfer technology to manufacture its innovative medicines in Vietnam.

Pfiser said it would bring its global technologies and operations platforms of hard-to-make products such as sterile injectables to Vietnam and help raise local manufacturing standards to that of international markets.

Under the agreement, Medochemie, which has a plant in Binh Duong Province, will make Pfiser’s anti-infective, cardiovascular, and pain drugs.

Commenting on the partnership, Bradley Allen Silcox, chief representative of Pfiser Thailand in Vietnam, said: “We are grateful to the Ministry of Health of Vietnam and the government of Vietnam for their vision to improve the capacity and capability of the pharmaceutical sector, and for creating an eco-sytem that allows patients the quality of care and treatment.

Daphne Pittas, director of Medochemie, said: “This partnership gives an impetus to Vietnam’s pharmaceutical industry capability for the manufacture of complex medicines such as oral dosages and injectable cephalosporin.

“Medochemie strongly believes in and will continue to support the scientific and technological advancement of the Vietnamese pharmaceutical sector.”

Vietnam is a rapidly developing market with a population of 95 million as of 2017. Steady economic growth and an expansion of the middle income have increased demand for high-quality healthcare goods and services, especially medicines, the two companies said in press release.


Category: Business, Vietnam

Print This Post